FREE SHIPPING ON ORDERS OVER $150

glp-1 pharmacokinetics receptor agonists in the treatment of type 2 diabetes – state-of-the-art Prediction of the pharmacokinetics of

$24.91

Quantity
- +
Description

In: Kamkin A., Lozinsky I., editors

glp-1 pharmacokinetics receptor agonists in the treatment of type 2 diabetes state-of-the-art Prediction of the pharmacokinetics of

It is not entirely clear to what extent endogenous GLP-1 activates all the reported GLP-1 receptor expressing neurons and to what extent it depends on the CART peptide especially in type 2 diabetes or obesity

glp-1 pharmacokinetics receptor agonists in the treatment of type 2 diabetes state-of-the-art Prediction of the pharmacokinetics of

Incretin hormones (such as Glucagon-like peptide

glp-1 pharmacokinetics receptor agonists in the treatment of type 2 diabetes state-of-the-art Prediction of the pharmacokinetics of

Additional Resources

glp-1 pharmacokinetics receptor agonists in the treatment of type 2 diabetes state-of-the-art Prediction of the pharmacokinetics of

You may also like

recommand products